Drug Discovery Outsourcing Market Size, Share & Trends Analysis Report By Workflow, By Drug, By Service, By Therapeutics Area, By End Use, By Region, And Segment Forecasts, 2026

The global drug discovery outsourcing market size was estimated at USD 8.08 billion in 2025 and is projected to reach USD 17.11 billion by 2033, growing at a CAGR of 10.0% from 2026 to 2033. The market growth is driven by increasing drug development activities, the growing complexity of therapeutics, rising R&D costs, and a growing need to accelerate time-to-market.

Besides, there is an increasing burden of diseases, a rising demand for novel modalities such as biologics and gene therapies, and the adoption of advanced technologies, including AI and high-throughput screening.

There are several other factors contributing to the market growth include the increasing outsourcing of discovery activities to access specialized expertise, advanced technologies, and scalable research infrastructure. In addition, growing adoption of AI-based drug discovery, increased demand for biologics, and targeted therapies are contributing to the market growth. Moreover, outsourcing enables risk sharing, operational flexibility, and cost optimization, making it an attractive strategy amid patent expirations and propelling competition in the global pharmaceutical landscape, which is expected to drive market growth.

The pharmaceutical industry has experienced significant transformations, including the expiration of patents, a trend toward biologics, and unprecedented downsizing of internal discovery of big pharmaceuticals, which is expected to drive the market growth. Besides, an increase in R&D funding and investments in novel drug development is a crucial trend in the biotechnology and pharmaceutical industries. For instance, around 75.0% to 80.0% of research and development spending in the biopharmaceutical industry can be outsourced, further propelling new growth opportunities for CROs, which is expected to boost market growth.

Pharmaceutical companies are partnering with manufacturing facilities in developing countries, backed by skilled workforces, low costs, and quality data. Cost-cutting, innovation, gaining access to knowledge and technology, and increasing speed and agility are significant factors encouraging pharma companies to expand the level of outsourcing. Moreover, there has been a considerable increase in interest from both private and public sectors in the development and discovery of innovative therapies. Several major pharmaceutical companies are investing in the development of novel solutions to establish a strong market position. There has also been a considerable increase in venture capital investments, especially in the life sciences sector.

Moreover, technological advancements are a fundamental driver shaping the growth and structural evolution of the global drug discovery outsourcing industry. The rising complexity of therapeutic targets, along with the industry's focus on increasing productivity and reducing attrition rates in early-stage research stages has led to greater adoption of advanced discovery technologies. As pharmaceutical and biotech companies reevaluate their internal capabilities, outsourcing partners with unique technological platforms, strengthening the position of contract research organizations (CROs) as innovation facilitators rather than just service providers.

Furthermore, the market competition is driven by high quality and strict compliance to regulations worldwide, international scientific excellence, especially in the most demanded research areas, speed and unbeatable timelines to delivery, and complex, competitive prices. In addition, companies are increasingly collaborating and leveraging expertise, which is expected to drive the drug discovery outsourcing industry. Organizations are undertaking & extending strategic partnerships with many academic institutions, venture capitalists for funding, and other public or private companies to exploit patented technology, molecules, and more. Rising partnerships among public and private entities accelerate drug discovery processes, increasing the global demand for outsourcing. In addition, emergence of various new startups across the hotspot countries, such as the U.S., India, China, South Korea, Singapore, & other Southeast Asian countries are contributing to the market's growth. For instance, in March 2025, Syngene International Limited announced the acquisition of its first biologics site in the USA, which includes several manufacturing lines for monoclonal antibodies (mAbs). The site was acquired from Emergent Manufacturing Operations in Baltimore, enhancing Syngene's expanding global presence in the biologics sector and enabling the company to serve clients in both the human and animal health markets.

Global Drug Discovery Outsourcing Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global drug discovery outsourcing market report based on workflow, drug, service, therapeutics area, end use, and region.

Workflow Outlook (Revenue, USD Million, 2021 - 2033)
Target Identification & Screening
Target Validation & Functional Informatics
Lead Identification & Candidate Optimization
Preclinical Development
Others
Drug Outlook (Revenue, USD Million, 2021 - 2033)
Small Molecules
Large Molecules
Service Outlook (Revenue, USD Million, 2021 - 2033)
Chemistry Services
Biology Services
Therapeutics Area Outlook (Revenue, USD Million, 2021 - 2033)
Respiratory system
Pain and Anesthesia
Oncology
Ophthalmology
Hematology
Cardiovascular
Endocrine
Gastrointestinal
Immunomodulation
Anti-infective
Central Nervous System
Dermatology
Genitourinary System
Others
End Use Outlook (Revenue, USD Million, 2021 - 2033)
Pharmaceutical & Biotechnology companies
Academic Institutes
Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
- U.S.
- Canada
- Mexico
Europe
- UK
- Germany
- France
- Italy
- Spain
- Sweden
- Denmark
- Norway
Asia Pacific
- Japan
- China
- India
- Thailand
- South Korea
- Australia
Latin America
- Brazil
- Argentina
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
- Oman
- Qatar

Product Code: GVR-2-68038-392-8

Chapter 1. Research Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Segment Definitions
- 1.2.1. Workflow
- 1.2.2. Drug
- 1.2.3. Service
- 1.2.4. Therapeutics Area
- 1.2.5. End Use
1.3. Research Methodology
1.4. Information Procurement
- 1.4.1. Purchased Database
- 1.4.2. GVR's Internal Database
- 1.4.3. Secondary Sources
- 1.4.4. Primary Research
1.5. Information Or Data Analysis
- 1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
- 1.7.1. Commodity Flow Analysis
- 1.7.2. Parent Market Analysis
1.8. List Of Secondary Sources
1.9. List Of Abbreviations
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Drug Discovery Outsourcing Market Variables, Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
  - 3.2.1.1. Increasing R&D in biopharmaceutical industry
  - 3.2.1.2. Increasing demand for outsourcing services in drug development
  - 3.2.1.3. Technological advancements in drug discovery
  - 3.2.1.4. Rising incidence rate of metabolic, genetic, and other chronic diseases
- 3.2.2. Market Restraint Analysis
  - 3.2.2.1. Presence of open-source software packages for drug discovery
  - 3.2.2.2. High operational costs and risk of drug failure
3.3. Pricing Model Analysis
3.4. Technology Landscape
3.5. Market Analysis Tools
- 3.5.1. Porter's Five Force Analysis
- 3.5.2. PESTEL by SWOT Analysis

Chapter 4. Drug Discovery Outsourcing Market: Workflow Estimates & Trend Analysis

4.1. Drug Discovery Outsourcing Market, By Workflow: Segment Dashboard
4.2. Drug Discovery Outsourcing Market, By Workflow: Movement Analysis
4.3. Drug Discovery Outsourcing Market Estimates & Forecasts, By Workflow, 2021 - 2033 (USD Million)
4.4. Target Identification & Screening
- 4.4.1. Target Identification & Screening Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5. Target Validation & Functional Informatics
- 4.5.1. Target Validation & Functional Informatics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6. Lead Identification & Candidate Optimization
- 4.6.1. Lead Identification & Candidate Optimization Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.7. Preclinical Development
- 4.7.1. Preclinical Development Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.8. Others
- 4.8.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Drug Discovery Outsourcing Market: Drug Estimates & Trend Analysis

5.1. Drug Discovery Outsourcing Market, By Drug: Segment Dashboard
5.2. Drug Discovery Outsourcing Market, By Drug: Movement Analysis
5.3. Drug Discovery Outsourcing Market Estimates & Forecasts, By Drug, 2021 - 2033 (USD Million)
5.4. Small Molecules
- 5.4.1. Small Molecules Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5. Large Molecules
- 5.5.1. Large Molecules Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Drug Discovery Outsourcing Market: Service Estimates & Trend Analysis

6.1. Drug Discovery Outsourcing Market, By Service: Segment Dashboard
6.2. Drug Discovery Outsourcing Market, By Service: Movement Analysis
6.3. Drug Discovery Outsourcing Market Estimates & Forecasts, By Service, 2021 - 2033 (USD Million)
6.4. Chemistry Services
- 6.4.1. Chemistry Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5. Biology Services
- 6.5.1. Biology Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Drug Discovery Outsourcing Market: Therapeutics Area Estimates & Trend Analysis

7.1. Drug Discovery Outsourcing Market, By Therapeutics Area: Segment Dashboard
7.2. Drug Discovery Outsourcing Market, By Therapeutics Area: Movement Analysis
7.3. Drug Discovery Outsourcing Market Estimates & Forecasts, By Therapeutics Area, 2021 - 2033 (USD Million)
7.4. Respiratory System
- 7.4.1. Respiratory System Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5. Pain and Anesthesia
- 7.5.1. Pain and Anesthesia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.6. Oncology
- 7.6.1. Oncology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.7. Ophthalmology
- 7.7.1. Ophthalmology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.8. Hematology
- 7.8.1. Hematology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.9. Cardiovascular
- 7.9.1. Cardiovascular Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.10. Endocrine
- 7.10.1. Endocrine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.11. Gastrointestinal
- 7.11.1. Gastrointestinal Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.12. Immunomodulation
- 7.12.1. Immunomodulation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.13. Anti-infective
- 7.13.1. Anti-infective Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.14. Central Nervous System
- 7.14.1. Central Nervous System Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.15. Dermatology
- 7.15.1. Dermatology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.16. Genitourinary System
- 7.16.1. Genitourinary System Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.17. Others
- 7.17.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Drug Discovery Outsourcing Market: End Use Estimates & Trend Analysis

8.1. Drug Discovery Outsourcing Market, By End Use: Segment Dashboard
8.2. Drug Discovery Outsourcing Market, By End Use: Movement Analysis
8.3. Drug Discovery Outsourcing Market Estimates & Forecasts, By End Use, 2021 - 2033 (USD Million)
8.4. Pharmaceutical & Biotechnology companies
- 8.4.1. Pharmaceutical & Biotechnology companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.5. Academic Institutes
- 8.5.1. Academic Institutes Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Drug Discovery Outsourcing Market: Regional Estimates & Trend Analysis

9.1. Regional Market Dashboard
9.2. Regional Market Share Analysis, 2025 & 2033
9.3. North America
- 9.3.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.3.2. U.S
  - 9.3.2.1. Key Country Dynamics
  - 9.3.2.2. Competitive Scenario
  - 9.3.2.3. Regulatory Framework
  - 9.3.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.3.3. Canada
  - 9.3.3.1. Key Country Dynamics
  - 9.3.3.2. Competitive Scenario
  - 9.3.3.3. Regulatory Framework
  - 9.3.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.3.4. Mexico
  - 9.3.4.1. Key Country Dynamics
  - 9.3.4.2. Competitive Scenario
  - 9.3.4.3. Regulatory Framework
  - 9.3.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.4. Europe
- 9.4.1. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.4.2. UK
  - 9.4.2.1. Key Country Dynamics
  - 9.4.2.2. Competitive Scenario
  - 9.4.2.3. Regulatory Framework
  - 9.4.2.4. UK Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.4.3. Germany
  - 9.4.3.1. Key Country Dynamics
  - 9.4.3.2. Competitive Scenario
  - 9.4.3.3. Regulatory Framework
  - 9.4.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.4.4. France
  - 9.4.4.1. Key Country Dynamics
  - 9.4.4.2. Competitive Scenario
  - 9.4.4.3. Regulatory Framework
  - 9.4.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.4.5. Italy
  - 9.4.5.1. Key Country Dynamics
  - 9.4.5.2. Competitive Scenario
  - 9.4.5.3. Regulatory Framework
  - 9.4.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.4.6. Spain
  - 9.4.6.1. Key Country Dynamics
  - 9.4.6.2. Competitive Scenario
  - 9.4.6.3. Regulatory Framework
  - 9.4.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.4.7. Denmark
  - 9.4.7.1. Key Country Dynamics
  - 9.4.7.2. Competitive Scenario
  - 9.4.7.3. Regulatory Framework
  - 9.4.7.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.4.8. Sweden
  - 9.4.8.1. Key Country Dynamics
  - 9.4.8.2. Competitive Scenario
  - 9.4.8.3. Regulatory Framework
  - 9.4.8.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.4.9. Norway
  - 9.4.9.1. Key Country Dynamics
  - 9.4.9.2. Competitive Scenario
  - 9.4.9.3. Regulatory Framework
  - 9.4.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.5. Asia Pacific
- 9.5.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.5.2. Japan
  - 9.5.2.1. Key Country Dynamics
  - 9.5.2.2. Competitive Scenario
  - 9.5.2.3. Regulatory Framework
  - 9.5.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.5.3. China
  - 9.5.3.1. Key Country Dynamics
  - 9.5.3.2. Competitive Scenario
  - 9.5.3.3. Regulatory Framework
  - 9.5.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.5.4. India
  - 9.5.4.1. Key Country Dynamics
  - 9.5.4.2. Competitive Scenario
  - 9.5.4.3. Regulatory Framework
  - 9.5.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.5.5. Thailand
  - 9.5.5.1. Key Country Dynamics
  - 9.5.5.2. Competitive Scenario
  - 9.5.5.3. Regulatory Framework
  - 9.5.5.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.5.6. South Korea
  - 9.5.6.1. Key Country Dynamics
  - 9.5.6.2. Competitive Scenario
  - 9.5.6.3. Regulatory Framework
  - 9.5.6.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.5.7. Australia
  - 9.5.7.1. Key Country Dynamics
  - 9.5.7.2. Competitive Scenario
  - 9.5.7.3. Regulatory Framework
  - 9.5.7.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.6. Latin America
- 9.6.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.6.2. Brazil
  - 9.6.2.1. Key Country Dynamics
  - 9.6.2.2. Competitive Scenario
  - 9.6.2.3. Regulatory Framework
  - 9.6.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.6.3. Argentina
  - 9.6.3.1. Key Country Dynamics
  - 9.6.3.2. Competitive Scenario
  - 9.6.3.3. Regulatory Framework
  - 9.6.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.7. MEA
- 9.7.1. MEA Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.7.2. South Africa
  - 9.7.2.1. Key Country Dynamics
  - 9.7.2.2. Competitive Scenario
  - 9.7.2.3. Regulatory Framework
  - 9.7.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.7.3. Saudi Arabia
  - 9.7.3.1. Key Country Dynamics
  - 9.7.3.2. Competitive Scenario
  - 9.7.3.3. Regulatory Framework
  - 9.7.3.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.7.4. UAE
  - 9.7.4.1. Key Country Dynamics
  - 9.7.4.2. Competitive Scenario
  - 9.7.4.3. Regulatory Framework
  - 9.7.4.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.7.5. Kuwait
  - 9.7.5.1. Key Country Dynamics
  - 9.7.5.2. Competitive Scenario
  - 9.7.5.3. Regulatory Framework
  - 9.7.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.7.6. Oman
  - 9.7.6.1. Key Country Dynamics
  - 9.7.6.2. Competitive Scenario
  - 9.7.6.3. Regulatory Framework
  - 9.7.6.4. Oman Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 9.7.7. Qatar
  - 9.7.7.1. Key Country Dynamics
  - 9.7.7.2. Competitive Scenario
  - 9.7.7.3. Regulatory Framework
  - 9.7.7.4. Qatar Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 10. Competitive Landscape

10.1. Market Participant Categorization
10.2. Company Market Share/Assessment Analysis, 2025
10.3. Company Profiles
- 10.3.1. Albany Molecular Research Inc. (Curia Global, Inc.)
  - 10.3.1.1. Company Overview
  - 10.3.1.2. Financial Performance
  - 10.3.1.3. Service Benchmarking
  - 10.3.1.4. Strategic Initiatives
- 10.3.2. EVOTEC
  - 10.3.2.1. Company Overview
  - 10.3.2.2. Financial Performance
  - 10.3.2.3. Service Benchmarking
  - 10.3.2.4. Strategic Initiatives
- 10.3.3. Laboratory Corporation of America Holdings.
  - 10.3.3.1. Company Overview
  - 10.3.3.2. Financial Performance
  - 10.3.3.3. Service Benchmarking
  - 10.3.3.4. Strategic Initiatives
- 10.3.4. GenScript
  - 10.3.4.1. Company Overview
  - 10.3.4.2. Financial Performance
  - 10.3.4.3. Service Benchmarking
  - 10.3.4.4. Strategic Initiatives
- 10.3.5. Thermo Fisher Scientific, Inc.
  - 10.3.5.1. Company Overview
  - 10.3.5.2. Financial Performance
  - 10.3.5.3. Service Benchmarking
  - 10.3.5.4. Strategic Initiatives
- 10.3.6. Charles River Laboratories International, Inc.
  - 10.3.6.1. Company Overview
  - 10.3.6.2. Financial Performance
  - 10.3.6.3. Service Benchmarking
  - 10.3.6.4. Strategic Initiatives
- 10.3.7. WuXi AppTec
  - 10.3.7.1. Company Overview
  - 10.3.7.2. Financial Performance
  - 10.3.7.3. Service Benchmarking
  - 10.3.7.4. Strategic Initiatives
- 10.3.8. Merck & Co., Inc.
  - 10.3.8.1. Company Overview
  - 10.3.8.2. Financial Performance
  - 10.3.8.3. Service Benchmarking
  - 10.3.8.4. Strategic Initiatives
- 10.3.9. Dalton Pharma Services
  - 10.3.9.1. Company Overview
  - 10.3.9.2. Financial Performance
  - 10.3.9.3. Service Benchmarking
  - 10.3.9.4. Strategic Initiatives
- 10.3.10. Oncodesign
  - 10.3.10.1. Company Overview
  - 10.3.10.2. Financial Performance
  - 10.3.10.3. Service Benchmarking
  - 10.3.10.4. Strategic Initiatives
- 10.3.11. Jubilant Biosys
  - 10.3.11.1. Company Overview
  - 10.3.11.2. Financial Performance
  - 10.3.11.3. Service Benchmarking
  - 10.3.11.4. Strategic Initiatives
- 10.3.12. QIAGEN
  - 10.3.12.1. Company Overview
  - 10.3.12.2. Financial Performance
  - 10.3.12.3. Service Benchmarking
  - 10.3.12.4. Strategic Initiatives
- 10.3.13. Eurofins SE
  - 10.3.13.1. Company Overview
  - 10.3.13.2. Financial Performance
  - 10.3.13.3. Service Benchmarking
  - 10.3.13.4. Strategic Initiatives
- 10.3.14. Syngene International Limited
  - 10.3.14.1. Company Overview
  - 10.3.14.2. Financial Performance
  - 10.3.14.3. Service Benchmarking
  - 10.3.14.4. Strategic Initiatives
- 10.3.15. Dr. Reddy Laboratories Ltd.
  - 10.3.15.1. Company Overview
  - 10.3.15.2. Financial Performance
  - 10.3.15.3. Service Benchmarking
  - 10.3.15.4. Strategic Initiatives
- 10.3.16. Pharmaron Beijing Co., Ltd.
  - 10.3.16.1. Company Overview
  - 10.3.16.2. Financial Performance
  - 10.3.16.3. Service Benchmarking
  - 10.3.16.4. Strategic Initiatives
- 10.3.17. TCG Lifesciences Pvt Ltd.
  - 10.3.17.1. Company Overview
  - 10.3.17.2. Financial Performance
  - 10.3.17.3. Service Benchmarking
  - 10.3.17.4. Strategic Initiatives
- 10.3.18. Domainex Ltd.
  - 10.3.18.1. Company Overview
  - 10.3.18.2. Financial Performance
  - 10.3.18.3. Service Benchmarking
  - 10.3.18.4. Strategic Initiatives

Chapter 11. Key Recommendations

Product Code: GVR-2-68038-392-8

List of Tables

Table 1 List of Tables
Table 2 List of Secondary Sources
Table 3 List of Abbreviations
Table 4 Global Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
Table 5 Global Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
Table 6 Global Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 7 Global Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
Table 8 Global Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 9 Global Drug Discovery Outsourcing Market Estimates and Forecasts, by Region, 2021 - 2033 (USD Million)
Table 10 North America Drug Discovery Outsourcing Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
Table 11 North America Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
Table 12 North America Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
Table 13 North America Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 14 North America Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
Table 15 North America Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 16 U . Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
Table 17 U.S Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
Table 18 U.S Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 19 U.S Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
Table 20 U.S Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 21 Canada Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
Table 22 Canada Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
Table 23 Canada Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 24 Canada Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
Table 25 Canada Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 26 Mexico Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
Table 27 Mexico Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
Table 28 Mexico Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 29 Mexico Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
Table 30 Mexico Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 31 Europe Drug Discovery Outsourcing Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
Table 32 Europe Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
Table 33 Europe Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
Table 34 Europe Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 35 Europe Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
Table 36 Europe Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 37 UK Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
Table 38 UK Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
Table 39 UK Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 40 UK Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
Table 41 UK Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 42 Germany Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
Table 43 Germany Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
Table 44 Germany Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 45 Germany Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
Table 46 Germany Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 47 France Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
Table 48 France Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
Table 49 France Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 50 France Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
Table 51 France Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 52 Italy Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
Table 53 Italy Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
Table 54 Italy Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 55 Italy Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
Table 56 Italy Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 57 Spain Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
Table 58 Spain Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
Table 59 Spain Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 60 Spain Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
Table 61 Spain Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 62 Denmark Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
Table 63 Denmark Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
Table 64 Denmark Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 65 Denmark Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
Table 66 Denmark Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 67 Sweden Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
Table 68 Sweden Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
Table 69 Sweden Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 70 Sweden Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
Table 71 Sweden Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 72 Norway Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
Table 73 Norway Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
Table 74 Norway Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 75 Norway Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
Table 76 Norway Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 77 Asia Pacific Drug Discovery Outsourcing Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
Table 78 Asia Pacific Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
Table 79 Asia Pacific Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
Table 80 Asia Pacific Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 81 Asia Pacific Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
Table 82 Asia Pacific Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 83 Japan Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
Table 84 Japan Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
Table 85 Japan Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 86 Japan Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
Table 87 Japan Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 88 China Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
Table 89 China Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
Table 90 China Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 91 China Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
Table 92 China Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 93 India Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
Table 94 India Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
Table 95 India Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 96 India Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
Table 97 India Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 98 Thailand Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
Table 99 Thailand Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
Table 100 Thailand Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 101 Thailand Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
Table 102 Thailand Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 103 South Korea Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
Table 104 South Korea Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
Table 105 South Korea Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 106 South Korea Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
Table 107 South Korea Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 108 Australia Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
Table 109 Australia Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
Table 110 Australia Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 111 Australia Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
Table 112 Australia Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 113 Latin America Drug Discovery Outsourcing Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
Table 114 Latin America Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
Table 115 Latin America Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
Table 116 Latin America Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 117 Latin America Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
Table 118 Latin America Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 119 Brazil Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
Table 120 Brazil Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
Table 121 Brazil Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 122 Brazil Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
Table 123 Brazil Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 124 Argentina Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
Table 125 Argentina Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
Table 126 Argentina Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 127 Argentina Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
Table 128 Argentina Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 129 Middle East & Africa Drug Discovery Outsourcing Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
Table 130 Middle East & Africa Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
Table 131 Middle East & Africa Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
Table 132 Middle East & Africa Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 133 Middle East & Africa Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
Table 134 Middle East & Africa Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 135 South Africa Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
Table 136 South Africa Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
Table 137 South Africa Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 138 South Africa Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
Table 139 South Africa Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 140 Saudi Arabia Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
Table 141 Saudi Arabia Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
Table 142 Saudi Arabia Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 143 Saudi Arabia Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
Table 144 Saudi Arabia Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 145 UAE Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
Table 146 UAE Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
Table 147 UAE Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 148 UAE Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
Table 149 UAE Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 150 Kuwait Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
Table 151 Kuwait Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
Table 152 Kuwait Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 153 Kuwait Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
Table 154 Kuwait Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 155 Oman Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
Table 156 Oman Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
Table 157 Oman Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 158 Oman Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
Table 159 Oman Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
Table 160 Qatar Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
Table 161 Qatar Drug Discovery Outsourcing Market Estimates and Forecasts, by Drug, 2021 - 2033 (USD Million)
Table 162 Qatar Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 163 Qatar Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
Table 164 Qatar Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Market formulation & validation
Fig. 6 Commodity flow analysis
Fig. 7 Value-chain-based sizing & forecasting
Fig. 8 QFD model sizing & forecasting
Fig. 9 Bottom-up approach
Fig. 10 Market snapshot
Fig. 11 Segment snapshot 1
Fig. 12 Segment snapshot 2
Fig. 13 Competitive landscape snapshot
Fig. 14 Parent market outlook, 2025 (USD Billion)
Fig. 15 Ancillary market outlook, 2025 (USD Billion)
Fig. 16 Drug Discovery Outsourcing Market Dynamics
Fig. 17 Porter's five forces analysis
Fig. 18 PESTEL analysis
Fig. 19 Drug Discovery Outsourcing Market: Workflow outlook and key takeaways
Fig. 20 Drug Discovery Outsourcing Market: Workflow movement analysis
Fig. 21 Target Identification & Screening Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 22 Target Validation & Functional Informatics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 23 Lead Identification & Candidate Optimization Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 24 Preclinical Development Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 25 Other Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 26 Drug Discovery Outsourcing Market: Drug outlook and key takeaways
Fig. 27 Drug Discovery Outsourcing Market: Drug movement analysis
Fig. 28 Small Molecules Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 29 Large Molecules Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 30 Drug Discovery Outsourcing Market: Service outlook and key takeaways
Fig. 31 Drug Discovery Outsourcing Market: Service movement analysis
Fig. 32 Chemistry Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 33 Biology Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 34 Drug Discovery Outsourcing Market: Therapeutics Area outlook and key takeaways
Fig. 35 Drug Discovery Outsourcing Market: Therapeutics Area movement analysis
Fig. 36 Respiratory system Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 37 Pain and Anesthesia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 38 Oncology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 39 Ophthalmology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 40 Hematology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 41 Cardiovascular Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 42 Endocrine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 43 Gastrointestinal Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 44 Immunomodulation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 45 Anti-infective Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 46 Central Nervous System Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 47 Dermatology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 48 Genitourinary System Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 49 Drug Discovery Outsourcing Market: End Use outlook and key takeaways
Fig. 50 Drug Discovery Outsourcing Market: End Use movement analysis
Fig. 51 Pharmaceutical & Biotechnology companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 52 Academic Institutes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 53 Regional Marketplace: Key Takeaways
Fig. 54 North America Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 55 Key country dynamics
Fig. 56 U.S. Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 57 Key country dynamics
Fig. 58 Canada Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 59 Key country dynamics
Fig. 60 Mexico Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 61 Europe Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 62 Key country dynamics
Fig. 63 UK Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 64 Key country dynamics
Fig. 65 Germany Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 66 Key country dynamics
Fig. 67 France Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 68 Key country dynamics
Fig. 69 Italy Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 70 Key country dynamics
Fig. 71 Spain Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 72 Key country dynamics
Fig. 73 Denmark Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 74 Key country dynamics
Fig. 75 Sweden Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 76 Key country dynamics
Fig. 77 Norway Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 78 Asia Pacific Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 79 Key country dynamics
Fig. 80 Japan Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 81 Key country dynamics
Fig. 82 China Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 83 Key country dynamics
Fig. 84 India Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 85 Key country dynamics
Fig. 86 Thailand Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 87 Key country dynamics
Fig. 88 South Korea Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 89 Key country dynamics
Fig. 90 Australia Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 91 Latin America Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 92 Key country dynamics
Fig. 93 Brazil Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 94 Key country dynamics
Fig. 95 Argentina Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 96 MEA Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 97 Key country dynamics
Fig. 98 South Africa Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 99 Key country dynamics
Fig. 100 Saudi Arabia Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 101 Key country dynamics
Fig. 102 UAE Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 103 Key country dynamics
Fig. 104 Kuwait Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 105 Key country dynamics
Fig. 106 Oman Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 107 Key country dynamics
Fig. 108 Qatar Drug Discovery Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 109 Key company categorization
Fig. 110 Service heat map analysis
Fig. 111 Strategic framework

Drug Discovery Outsourcing Market Size, Share & Trends Analysis Report By Workflow, By Drug, By Service, By Therapeutics Area, By End Use, By Region, And Segment Forecasts, 2026 - 2033

Description

Table of Contents

List of Tables

Drug Discovery Outsourcing Market Summary

Table of Contents

Chapter 1. Research Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Drug Discovery Outsourcing Market Variables, Trends & Scope

Chapter 4. Drug Discovery Outsourcing Market: Workflow Estimates & Trend Analysis

Chapter 5. Drug Discovery Outsourcing Market: Drug Estimates & Trend Analysis

Chapter 6. Drug Discovery Outsourcing Market: Service Estimates & Trend Analysis

Chapter 7. Drug Discovery Outsourcing Market: Therapeutics Area Estimates & Trend Analysis

Chapter 8. Drug Discovery Outsourcing Market: End Use Estimates & Trend Analysis

Chapter 9. Drug Discovery Outsourcing Market: Regional Estimates & Trend Analysis

Chapter 10. Competitive Landscape

Chapter 11. Key Recommendations

List of Tables

List of Figures